UPDATED Mar 30, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
AZN | UK£106.78 | 1.9% | -4.9% | UK£165.5b | UK£125.57 | PE35.1x | E16.4% | 2.1% | Pharmaceuticals & Biotech | ||
GSK | UK£17.09 | 1.3% | 19.6% | UK£69.8b | UK£19.63 | PE14.2x | E9.4% | 3.4% | Pharmaceuticals & Biotech | ||
SN. | UK£9.92 | -4.6% | -11.6% | UK£8.6b | UK£13.08 | PE41.5x | E21.3% | 3.0% | Healthcare | ||
CTEC | UK£2.86 | -1.0% | 25.3% | UK£5.9b | UK£3.03 | PE56.8x | E20.6% | 1.7% | Healthcare | ||
DPH | UK£38.66 | 0.2% | 32.4% | UK£4.4b | UK£37.59 | PS5.8x | E62.5% | 0% | Pharmaceuticals & Biotech | ||
HIK | UK£19.19 | 0.2% | 14.5% | UK£4.3b | UK£22.94 | PE28.3x | E18.1% | 3.0% | Pharmaceuticals & Biotech | ||
MDC | UK£5.01 | 0.1% | 25.4% | UK£3.7b | UK£4.95 | PE21.9x | E10.7% | 0.6% | Healthcare | ||
INDV | UK£16.94 | 3.0% | 22.3% | UK£2.3b | UK£24.82 | PE1452.7x | E32.8% | 0% | Pharmaceuticals & Biotech | ||
HCM | UK£2.68 | 2.1% | 21.6% | UK£2.3b | UK£4.29 | PE28.6x | E19.0% | n/a | Pharmaceuticals & Biotech | ||
EMIS | UK£19.20 | 0.1% | 2.8% | UK£1.2b | UK£19.25 | PE40.4x | E11.0% | 2.2% | Healthcare | ||
GNS | UK£17.65 | -3.6% | -38.6% | UK£1.2b | UK£29.62 | PE34.6x | E26.0% | 1.8% | Pharmaceuticals & Biotech | ||
ONT | UK£1.22 | -5.5% | -45.4% | UK£1.0b | UK£2.20 | PS6.2x | E21.1% | n/a | Pharmaceuticals & Biotech | ||
SPI | UK£2.32 | 0.4% | 9.2% | UK£936.9m | UK£2.99 | PE34.3x | E29.1% | 0.9% | Healthcare | ||
CRW | UK£22.00 | -0.9% | 91.3% | UK£769.5m | UK£26.82 | PE103.7x | E28.5% | 1.3% | Healthcare | ||
CVSG | UK£9.75 | -4.3% | -47.4% | UK£699.3m | UK£19.14 | PE19.8x | E14.0% | 0.8% | Healthcare | ||
ERGO | UK£13.46 | 0.1% | 3.5% | UK£701.1m | UK£14.34 | PE46.7x | E14.2% | n/a | Pharmaceuticals & Biotech | ||
PRTC | UK£2.23 | 3.0% | 0.5% | UK£601.2m | UK£4.65 | PS64.6x | E-3.8% | n/a | Pharmaceuticals & Biotech | ||
AMS | UK£1.96 | 5.0% | -11.9% | UK£426.0m | UK£2.53 | PE26.8x | E11.7% | 1.2% | Healthcare | ||
MXCT | UK£3.43 | -2.8% | -12.2% | UK£356.6m | UK£7.66 | PS10.9x | E-6.2% | n/a | Pharmaceuticals & Biotech | ||
NIOX | UK£0.64 | -3.3% | 37.6% | UK£271.3m | n/a | PE28.6x | E16.9% | 1.6% | Pharmaceuticals & Biotech | ||
BVXP | UK£44.50 | -3.3% | 13.4% | UK£232.3m | UK£59.00 | PE26.8x | E5.2% | 3.4% | Pharmaceuticals & Biotech | ||
APH | UK£0.40 | 1.8% | -42.5% | UK£214.5m | n/a | PS1.3x | E46.4% | 0% | Pharmaceuticals & Biotech | ||
TSTL | UK£4.35 | -2.8% | 32.8% | UK£206.6m | UK£4.82 | PE34.2x | E5.8% | 2.4% | Healthcare | ||
OXB | UK£2.01 | 2.1% | -53.7% | UK£200.9m | UK£4.15 | PS1.7x | E52.4% | n/a | Pharmaceuticals & Biotech |